Literature DB >> 9543346

Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats.

M L Battell1, H L Delgatty, J H McNeill.   

Abstract

Sodium selenate, administered intraperitoneally (i.p.), resulted in an improvement in glucose tolerance in treated diabetic rats. Fed rat plasma glucose levels were reduced by selenate treatment in streptozotocin diabetic rats. The lowest values of blood glucose were reached within 3 weeks of beginning the treatment. Food and fluid consumption was reduced in treated compared to untreated diabetic rats. Diabetic treated rats did not release insulin in response to a glucose challenge and insulin release in response to a challenge was markedly reduced in control treated rats. Assessment of heart function using a working heart apparatus showed that treated diabetic rats with improved blood glucose levels had normal heart function at 8 weeks of diabetes in contrast to hearts from non-treated diabetics. This study extends previous observations on the in vivo insulin-like effects of sodium selenate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9543346     DOI: 10.1023/a:1006819227506

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  Identification of type I iodothyronine 5'-deiodinase as a selenoenzyme.

Authors:  D Behne; A Kyriakopoulos; H Meinhold; J Köhrle
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

2.  Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats.

Authors:  S M Brichard; W Okitolonda; J C Henquin
Journal:  Endocrinology       Date:  1988-10       Impact factor: 4.736

Review 3.  Heart triglycerides in health and disease.

Authors:  J C Shipp; L A Menahan; M F Crass; S N Chaudhuri
Journal:  Recent Adv Stud Cardiac Struct Metab       Date:  1973

4.  Oral vanadyl sulfate in treatment of diabetes mellitus in rats.

Authors:  S Ramanadham; J J Mongold; R W Brownsey; G H Cros; J H McNeill
Journal:  Am J Physiol       Date:  1989-09

5.  Vanadate treatment of streptozotocin diabetic rats restores expression of the insulin-responsive glucose transporter in skeletal muscle.

Authors:  H V Strout; P P Vicario; C Biswas; R Saperstein; E J Brady; P F Pilch; J Berger
Journal:  Endocrinology       Date:  1990-05       Impact factor: 4.736

6.  Selenium: biochemical role as a component of glutathione peroxidase.

Authors:  J T Rotruck; A L Pope; H E Ganther; A B Swanson; D G Hafeman; W G Hoekstra
Journal:  Science       Date:  1973-02-09       Impact factor: 47.728

7.  Role of cytosolic tyrosine kinase in mediating insulin-like actions of vanadate in rat adipocytes.

Authors:  A Shisheva; Y Shechter
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

8.  Abundance and tissue distribution of selenocysteine-containing proteins in the rat.

Authors:  W C Hawkes; E C Wilhelmsen; A L Tappel
Journal:  J Inorg Biochem       Date:  1985-02       Impact factor: 4.155

9.  Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats.

Authors:  C E Heyliger; A G Tahiliani; J H McNeill
Journal:  Science       Date:  1985-03-22       Impact factor: 47.728

10.  Studies on the relations of selenium and Keshan disease.

Authors:  X Chen; G Yang; J Chen; X Chen; Z Wen; K Ge
Journal:  Biol Trace Elem Res       Date:  1980-06       Impact factor: 3.738

View more
  13 in total

Review 1.  The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities.

Authors:  Zhi Huang; Aaron H Rose; Peter R Hoffmann
Journal:  Antioxid Redox Signal       Date:  2012-01-09       Impact factor: 8.401

2.  Selenate enhances STAT3 transcriptional activity in endothelial cells: differential actions of selenate and selenite on LIF cytokine signaling and cell viability.

Authors:  Hani J Alturkmani; Carlos Zgheib; Fouad A Zouein; Nour Eddin F Alshaaer; Mazen Kurdi; George W Booz
Journal:  J Inorg Biochem       Date:  2012-01-28       Impact factor: 4.155

3.  Impacts of dietary selenium deficiency on metabolic phenotypes of diet-restricted GPX1-overexpressing mice.

Authors:  Matthew P Pepper; Marko Z Vatamaniuk; Xi Yan; Carol A Roneker; Xin Gen Lei
Journal:  Antioxid Redox Signal       Date:  2010-09-29       Impact factor: 8.401

Review 4.  Molecular and ionic mimicry and the transport of toxic metals.

Authors:  Christy C Bridges; Rudolfs K Zalups
Journal:  Toxicol Appl Pharmacol       Date:  2005-05-01       Impact factor: 4.219

5.  Dietary selenium deficiency partially rescues type 2 diabetes-like phenotypes of glutathione peroxidase-1-overexpressing male mice.

Authors:  Xi Yan; Matthew P Pepper; Marko Z Vatamaniuk; Carol A Roneker; Li Li; Xin Gen Lei
Journal:  J Nutr       Date:  2012-09-26       Impact factor: 4.798

6.  Selenium acts as an insulin-like molecule for the down-regulation of diabetic symptoms via endoplasmic reticulum stress and insulin signalling proteins in diabetes-induced non-obese diabetic mice.

Authors:  Daeyoun Hwang; Sujin Seo; Yongkyu Kim; Chuelkyu Kim; Sunbo Shim; Seungwan Jee; Suhae Lee; Mikyong Jang; Minsun Kim; Suyoun Yim; Sang-Koo Lee; Byeongcheol Kang; Insurk Jang; Jungsik Cho
Journal:  J Biosci       Date:  2007-06       Impact factor: 1.826

Review 7.  Regulation and function of selenoproteins in human disease.

Authors:  Frederick P Bellinger; Arjun V Raman; Mariclair A Reeves; Marla J Berry
Journal:  Biochem J       Date:  2009-07-29       Impact factor: 3.857

Review 8.  Selenium and diabetes--evidence from animal studies.

Authors:  Jun Zhou; Kaixun Huang; Xin Gen Lei
Journal:  Free Radic Biol Med       Date:  2013-07-16       Impact factor: 7.376

9.  Trace elements in diabetic cardiomyopathy: An electrophysiological overview.

Authors:  Nihal Ozturk; Yusuf Olgar; Semir Ozdemir
Journal:  World J Diabetes       Date:  2013-08-15

10.  Altered mechanical and electrical activities of the diabetic heart: Possible use of new therapeutics?

Authors:  Belma Turan; Mehmet Ugur; Semir Ozdemir; Nazmi Yaras
Journal:  Exp Clin Cardiol       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.